Molecular alterations in the pathogenesis of endometrial adenocarcinoma. Therapeutic implications.

Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Laura CerezoHelen Michael

Abstract

Molecular genetic evidence indicates that endometrial carcinoma likely develops as the result of a multistep process of oncogene activation and tumor suppressor gene inactivation. These molecular alterations appear to be specific for Type I (endometrioid) and Type II (non endometrioid) cancers. Type I cancers are characterized by mutation of PTEN, KRAS2, defects in DNA mismatch repair, as evidenced by the microsatellite instability phenotype, and a near diploid karyotype. Type II cancers often contain mutations of TP53 and Her-2/neu and are usually nondiploid. The clinical value of many of these molecular markers is now being tested and it may help to refine diagnosis and establish an accurate prognosis. Furthermore, some of these tumor biomarkers constitute the targets for emerging therapies. Transtuzumab against Her-2/neu and bevacizumab against VEGF overexpressing carcinomas are among the promising novel treatments. Additional translational research is needed to identify molecular and genetic alterations with potential for therapeutic interventions.

References

Jul 15, 1996·International Journal of Radiation Oncology, Biology, Physics·A KonskiW Eggleston
Aug 21, 1996·Journal of the National Cancer Institute·N PotischmanJ R Lurain
Sep 1, 1996·Clinical Obstetrics and Gynecology·M P Evans, K C Podratz
Jan 1, 1997·Archives of Gynecology and Obstetrics·J BackeH Caffier
Oct 24, 1998·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·R J ZainoV L Brunetto
Apr 15, 1999·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·C D RolitskyT H Niemann
May 20, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H B SalvesenL A Akslen
Sep 10, 1999·Gynecologic Oncology·J P GeislerW Crabtree
Dec 22, 1999·Experimental and Molecular Pathology·J A WilliamsS R Young
Mar 31, 2000·Gynecologic Oncology·M B SilvermanK C Podratz
Mar 31, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·N SekiT Kudo
Jun 8, 2000·Journal of the National Cancer Institute·G L MutterC Eng
Jun 28, 2000·American Journal of Obstetrics and Gynecology·A MarianiK C Podratz
Feb 13, 2001·British Journal of Cancer·M SaegusaI Okayasu
Jul 31, 2001·Molecular Pathology : MP·C S Herrington
Feb 28, 2002·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Caroline LundgrenB Nordström
Mar 27, 2002·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·A ØrboS Lysne
Apr 19, 2002·Biochimica Et Biophysica Acta·Karen H Vousden
Aug 23, 2002·Experimental Biology and Medicine·Roman MiturskiDominique Burnouf
Aug 24, 2002·American Journal of Obstetrics and Gynecology·Toshihiro OhkouchiSeiichiro Fujimoto
Nov 21, 2002·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·G von MinckwitzM Kaufmann
Feb 14, 2003·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Helga B Salvesen, Lars A Akslen
Feb 19, 2003·Analytical Cellular Pathology : the Journal of the European Society for Analytical Cellular Pathology·Pauline WimbergerRainer Kimmig
May 7, 2003·Proceedings of the National Academy of Sciences of the United States of America·Paul J GoodfellowDavid G Mutch
Jun 24, 2003·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·Ozlem ErdemAhmet Erdem
Dec 4, 2003·Cancer Detection and Prevention·Andrea MarianiKarl C Podratz
Apr 16, 2004·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·Abdulmohsen AlkushiC Blake Gilks
Jun 10, 2004·Human Pathology·Jaime Prat
Jul 31, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Brian M SlomovitzKaren H Lu
Aug 7, 2004·Gynecologic Oncology·J M A PijnenborgP G Groothuis
Dec 16, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H ToyokiT Tamaya
May 17, 2005·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Nicola RagniEzio Fulcheri

❮ Previous
Next ❯

Citations

May 29, 2007·Journal of Cancer Research and Clinical Oncology·I AlldingerC Poremba
Feb 11, 2014·Gynecologic Oncology·Paulette Mhawech-FaucegliaTanja Pejovic
May 23, 2012·PloS One·Felix RückertChristian Pilarsky
Jun 21, 2011·The Journal of Surgical Research·Felix RückertChristian Pilarsky
Jun 24, 2008·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Angiolo GadducciAndrea Riccardo Genazzani
Oct 26, 2012·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Pan Xiao-YuL Hua-Jun
Apr 19, 2017·Oncotarget·Ya LiHua-Bin Li
Jan 1, 2008·Journal of Inorganic and Organometallic Polymers and Materials·Michael R RonerGirish Barot

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.